[The role of H2RA in the eradication therapy of Helicobacter pylori].
Yakabi
Koji
K
Third Department of Internal Medicine, Teikyo University School of Medicine.
Nakamura
Takashi
T
D000658:Amoxicillin / Q000494:pharmacology / Q000627:therapeutic use; D017291:Clarithromycin / Q000494:pharmacology / Q000627:therapeutic use; D003864:Depression, Chemical; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D005744:Gastric Acid / Q000378:metabolism; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects; D006635:Histamine H2 Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D011899:Ranitidine / Q000494:pharmacology / Q000627:therapeutic use*
D006635:Histamine H2 Antagonists; D000658:Amoxicillin; D011899:Ranitidine; D017291:Clarithromycin